Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis.

MLA

Alshaikheid, Mohammed, et al. “Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis.” Journal of Clinical Pharmacology, vol. 61, no. 7, July 2021, pp. 972–78. EBSCOhost, https://doi.org/10.1002/jcph.1813.

APA

Alshaikheid, M., Romdhane, H. B., Fredj, N. B., Fadhel, N. B., Aouam, A., Chadli, Z., Boughattas, N., Chaabane, A., & Aouam, K. (2021). Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis. Journal of Clinical Pharmacology, 61(7), 972–978. https://doi.org/10.1002/jcph.1813

Chicago

Alshaikheid, Mohammed, Haifa Ben Romdhane, Nadia Ben Fredj, Najah Ben Fadhel, Abir Aouam, Zohra Chadli, Naceur Boughattas, Amel Chaabane, and Karim Aouam. 2021. “Isoniazid Therapeutic Drug Monitoring in Tunisian Patients With Tuberculosis.” Journal of Clinical Pharmacology 61 (7): 972–78. doi:10.1002/jcph.1813.